Savicell Diagnostics Plans To Raise $30M

October 9, 2013 | Israeli company Savicell Diagnostics, which is developing a blood test for early detection of cancer, is in the process of raising $30 million. “Globes” reports that Savicell is in talks to raise $30 million from Exact Sciences Corporation, an American company that has developed a stool sample test for colon cancer. The companies also discussed a possible acquisition of Savicell.